# Reinvestment

> Reinvestment is a VC fund in Seoul backing Medical, Manufacturing and Medical Device. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 6
- Last investment: Feb 2026
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.cncipartners.com

Reinvestment is an investment company that offers financial and business support services to entrepreneurs.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.7M–$5.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 67% |
| Manufacturing | 3 | 50% |
| Medical Device | 3 | 50% |
| Software | 2 | 33% |
| Health Care | 2 | 33% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Seed | 1 | 17% |
| Series B | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Willog | As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia. |  | Series B | Feb 03, 2026 |  |
| AIRS Medical | AIRS Medical is an MRI reconstruction software service provider. | $3.4K | Venture - Series Unknown | Mar 12, 2025 |  |
| AIRS Inc. | AIRS is at the forefront of advancing orthopedic surgery, setting the stage for the future with its innovative surgical platforms. The company is preparing for the next era in surgical technology, known as SURGERY 4.0. By leading the way with cutting-edge solutions, AIRS aims to transform orthopedic procedures, enhance precision, and redefinestandards in surgical care. | $3.4M | Series A | Mar 11, 2025 |  |
| Raywatt | Raywatt is a medical device company developing optical coherence tomography (OCT) imaging systems used for cardiovascular diagnosis. Its technology helps doctors visualize coronary arteries in detail to support evaluation of heart conditions during medical procedures. The company focuses on improving diagnostic imaging tools for interventionalcardiology and enhancing clinical decision-making through improved vessel visualization and data accuracy. | $5.9M | Series A | Mar 06, 2025 |  |
| NanoX | NanoX is a micro and mini LED inspection equipment company that offers designing and manufacturing servicesof semiconductors products. | $4.6M | Seed | Feb 15, 2022 |  |
| Medihub | Medihub offers an automatic injector "i-Ject" that reduces the injection pain for patients and convenience of procedure for doctors. | $1.7M | Series A | Dec 12, 2021 |  |

6 of 6 investments shown.

## Co-investors
- [L&S Venture Capital](https://shizune.co/investors/profile/l-s-venture-capital) — VC Fund, 3 deals together
- [Korea Technology Finance Corporation](https://shizune.co/investors/profile/korea-technology-finance-corporation) — VC Fund, 2 deals together
- [ON ventures](https://shizune.co/investors/profile/on-ventures-45b4) — VC Fund, 2 deals together
- [SL Investment](https://shizune.co/investors/profile/sl-investment) — VC Fund, 2 deals together
- [Big Basin Capital](https://shizune.co/investors/profile/big-basin-capital) — VC Fund, 1 deal together
- [DAWON Asset Management](https://shizune.co/investors/profile/dawon-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Medical Device Investors in South Korea](https://shizune.co/investors/medical-device-investors-south-korea)
- [Medical Device VC Funds in South Korea](https://shizune.co/investors/medical-device-vc-funds-south-korea)

## FAQ

### What does Reinvestment invest in?

Reinvestment invests primarily in Medical, Manufacturing and Medical Device startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Reinvestment's check size?

Reinvestment typically joins rounds of $1.7M–$5.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Reinvestment participates in.

### When did Reinvestment last invest?

The most recent investment recorded for Reinvestment closed in Feb 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co